Key result
Women with atrial fibrillation and heart failure are significantly underrepresented in clinical trials and are approximately half as likely as men to undergo catheter ablation.
Why the study?
Sex-related differences are recognized in catheter ablation for atrial fibrillation, but conflicting data exist regarding how gender interacts with heart failure to affect peri-ablation and post-ablation outcomes.
Are there sex-related differences in referral rates and clinical outcomes for catheter ablation in patients with atrial fibrillation and heart failure?
Are there sex-related differences in referral rates and clinical outcomes for catheter ablation in patients with atrial fibrillation and heart failure?
Women with atrial fibrillation and heart failure are significantly underrepresented in clinical trials and less likely to be referred for catheter ablation, highlighting a need for prospective studies with higher proportions of female participants to clarify sex-based outcome differences.
Women with AF-HF face referral bias and trial underrepresentation; leaves open sex-specific ablation outcomes and requires enriched prospective trials.
The coexistence of atrial fibrillation and heart failure significantly increases the risk of all-cause mortality and heart failure hospitalizations. Sex-related differences in all patients undergoing atrial fibrillation catheter ablation include the referral of fewer women for catheter ablation (15-25%), older age of women at ablation, and higher risk of post-ablation recurrence of atrial fibrillation. We searched the existing literature for sex-related differences in patients undergoing atrial fibrillation catheter ablation with a focus on heart failure. Randomized controlled trials assessing atrial fibrillation catheter ablation in patients with heart failure have demonstrated a significant reduction in all-cause mortality and heart failure hospitalizations. Within the eight existing randomized controlled trials on heart failure with reduced ejection fraction, women composed a small proportion of the study population. Only two studies (CASTLE-AF and AATAC-HF) specifically assessed the effect of gender on outcome and showed no difference in post-ablation outcomes. Registry data-based studies assessing sex-related differences in atrial fibrillation catheter ablation in heart failure reveal that women are half as likely as men to undergo ablation. Conflicting data exist on the interaction of gender and heart failure as they may affect peri-ablation and post-ablation long-term outcomes such as atrial fibrillation recurrence or heart failure hospitalizations. In conclusion, existing studies provide insight into the gender-based differences in patients undergoing catheter ablation for atrial fibrillation as it pertains to heart failure. Further prospective studies with higher proportions of female participants are required to accurately determine gender-based differences in this population.
No takes yet. Share an insight, caveat, or question.
Chibber et al. (2020) conducted a review in Atrial fibrillation and heart failure. Catheter ablation vs. Medical therapy / Men was evaluated. Women with atrial fibrillation and heart failure are significantly underrepresented in clinical trials and are approximately half as likely as men to undergo catheter ablation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: